Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Depressive Disorder, Treatment-resistant”

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07153406
What this trial is testing

Comparison of Esketamine Nasal Spray vs.Aripiprazole in Treat.Resistant Major Depressive Disorder in Elderly Patients

Who this might be right for
Depressive Disorder
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 220
Large-scale testing (Phase 3)WithdrawnNCT00276978
What this trial is testing

Aripiprazole Augmentation Therapy in Treatment-resistant Depression

Who this might be right for
Therapy-resistant Depression
University Hospital Freiburg
Post-approval studies (Phase 4)Study completedNCT03149991
What this trial is testing

Brexpiprazole Plus Ketamine in Treatment-Resistant Depression (TRD)

Who this might be right for
Depression
Massachusetts General Hospital 51
Post-approval studies (Phase 4)UnknownNCT04234776
What this trial is testing

Intramuscular Ketamine Versus Aripiprazole and Escitalopram in the Treatment of Resistant Depression

Who this might be right for
Depressive Disorder
University of Sao Paulo 88
Not applicableLooking for participantsNCT07094789
What this trial is testing

Focused Ultrasound Neuromodulation in Patients With Treatment-Resistant Depression

Who this might be right for
Treatment-Resistant DepressionTreatment-resistant Depression (TRD)
Sunnybrook Health Sciences Centre 20
Testing effectiveness (Phase 2)Ended earlyNCT04634669
What this trial is testing

Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)

Who this might be right for
Treatment Resistant DepressionMajor Depressive Disorder
Axsome Therapeutics, Inc. 181
Post-approval studies (Phase 4)Looking for participantsNCT07369102
What this trial is testing

Esketamine With or Without Integration Therapy for Treatment-Resistant Depression

Who this might be right for
Treatment-resistant Depression (TRD)
University of Puerto Rico 20
Not applicableStudy completedNCT05913401
What this trial is testing

Exercise to Augment TMS in Those With Treatment Resistant Depression

Who this might be right for
Treatment Resistant Depression
Butler Hospital 26
Not applicableStudy completedNCT03953417
What this trial is testing

Pilot Accelerated Theta Burst in Treatment-Resistant Bipolar Depression

Who this might be right for
Treatment Resistant Depression
Stanford University 7
Not applicableUnknownNCT06172413
What this trial is testing

Transcranial Alternating Current Stimulation for Treatment-Resistant Depression

Who this might be right for
Treatment-Resistant Depression
Xuanwu Hospital, Beijing 200
Not applicableUnknownNCT04354935
What this trial is testing

Treatment of Resistant Depression by Repetitive Transcranial Magnetic Stimulation (rTMS) Multicentric Naturalistic Study

Who this might be right for
To Evaluate the Effectiveness of Open rTMS
Centre hospitalier de Ville-Evrard, France 160
Testing effectiveness (Phase 2)UnknownNCT05383313
What this trial is testing

Psilocybin Versus Ketamine in Treatment-Resistant Depression

Who this might be right for
Treatment Resistant Depression
National Institute of Mental Health, Czech Republic 60
Not applicableLooking for participantsNCT06938841
What this trial is testing

Maintenance rTMS for Depression (Maitr-De)

Who this might be right for
Major Depressive DisorderTreatment Resistant Depression
University of California, San Diego 75
Post-approval studies (Phase 4)UnknownNCT01699490
What this trial is testing

Role of Inflammation Factors and Insulin Resistance in Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
National Cheng-Kung University Hospital 200
Large-scale testing (Phase 3)Study completedNCT01945047
What this trial is testing

Action of Ketamine in Treatment-Resistant Depression

Who this might be right for
Treatment-resistant Depression
University of Ottawa 46
Large-scale testing (Phase 3)Study completedNCT03434041
What this trial is testing

Evaluate the Efficacy, Pharmacokinetics, Safety and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression

Who this might be right for
Depressive Disorder, Treatment-Resistant
Janssen Research & Development, LLC 252
Early research (Phase 1)UnknownNCT01239888
What this trial is testing

Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot Study

Who this might be right for
DepressionMajor Depressive Disorder
The Alfred 15
Not applicableLooking for participantsNCT06599099
What this trial is testing

Deep Brain Stimulation of Treatment-Resistant Bipolar Depression

Who this might be right for
Bipolar Depression
Wayne Goodman MD 10
Not applicableStudy completedNCT01944644
What this trial is testing

Low Field Magnetic Stimulation for Treatment Resistant Depression

Who this might be right for
Treatment Resistant Depression
Weill Medical College of Cornell University 66
Not applicableLooking for participantsNCT05833087
What this trial is testing

Schema Therapy for Patients With Chronic Treatment Resistant Depression

Who this might be right for
Treatment Resistant DepressionChronic Depression
Region of Southern Denmark 129
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation